Hydration monitor
A non-invasive method to measure hydration could have applications not only in the hospital, but also at the bedsides of assisted-living patients, among athletes and even in developing countries.
Transforming pediatric care and reducing costs Children's has partnered with primary care physicians and insurers to better integrate care and develop innovative approaches and care models, piloted programs that have improved health outcomes and reduced costs, and renewed its focus on prevention.
Gene therapy makes a comeback
Gene therapy holds the promise to cure a variety of diseases caused by single-gene mutations. The first gene-therapy trial for SCID-X1 to be approved by the FDA is sponsored in the U.S. by Children's Hospital Boston's David A. Williams, MD, chief of Hematology/Oncology and director of Translational Research.
Clinical trial will seek to calm down sickle-cell disease
Now, a multicenter clinical trial is exploring whether a drug used in cardiovascular stress testing, Lexiscan, could ease that inflammation and reduce sickle-cell symptoms, particularly pain and acute chest syndrome.
Cerebrovascular Disorders and Stroke Program
Cerebrovascular disorders are among the top 10 causes of death in children. This program offers rapid diagnosis and treatment from a team of subspecialists who deliver treatment that minimizes long-term damage to the brain.
Head lice Claire McCarthy, MD, discusses the AAP ës clinical report and offers advice on identification and treatment.
The articles in Pediatric Views are provided for general informational purposes, and should not be used as the basis for medical advice, investment, or any other purpose.
Background information, descriptions of medical science and care, information on research discoveries, and predictions about the evolution of science
are not intended to be a guide to patient diagnosis or treatment, or relied on for any other purpose. Please contact us if we can be helpful in answering
any questions or to arrange for a medical visit or consult.
